Kongsberg, November 10, 2020 – Kongsberg Beam Technology has received a Notice of Allowance from the US Patent and Trademark Office.
The notice relates to Kongsberg Beam Technology’s first patent family that protects the design of the MAMA-K system, and includes a particle beam guiding system, method, and related radiotherapy system. The company has filed for patent approval around the world and will continue, focusing on its leading-edge technology and enhance patient’s well-being while undergoing proton therapy.